Background Pretreatment drug resistance in people initiating or re-initiating antiretroviral
therapy (ART) containing non-nucleoside reverse transcriptase inhibitors (NNRTIs) might …

Background Global genetic diversity of HIV-1 is a major challenge to the development of HIV
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …

2 months ago, when the numbers known to have died from Ebola in west Africa could still be
counted in hundreds, WHO made an important statement about investigational drugs and …

The effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on
disease progression was investigated in 1045 adults in Uganda. At enrollment and every 6 …

Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …

Background Dyslipidaemia is highly prevalent in individuals with type 2 diabetes mellitus (T2DM).
Numerous studies have sought to disentangle the causal relationship between …

The dynamic change in HIV subtype distribution presents future challenges for diagnosis,
treatment and vaccine design and development. An increase in recombinant viruses suggests …

Triglycerides are transported in plasma by specific triglyceride-rich lipoproteins; in
epidemiological studies, increased triglyceride levels correlate with higher risk for coronary artery …

Given the importance of Africa to studies of human origins and disease susceptibility, detailed
characterization of African genetic diversity is needed. The African Genome Variation …

Scavenger receptor BI (SR-BI) is the major receptor for high-density lipoprotein (HDL)
cholesterol (HDL-C). In humans, high amounts of HDL-C in plasma are associated with a lower …